business
Pharma IQ’s Power List 2022
September 15 by Pharma IQPharma IQ launches its inaugural list of the 20 most influential people in the pharma sector.
Group class action: An emerging legal risk for pharma businesses
August 16 by Michael FrisbySolicitor Michael Frisby explains why group class action is a growing risk for pharmaceutical firms
The five biggest winners in pharma of 2022 so far
August 03 by Leila HawkinsPharma IQ looks at the five most profitable pharma companies of 2022 so far
The top 10 pharma companies on the 2022 Fortune 500 list
May 27 by Leila HawkinsWe look at the top 10 pharmaceutical companies on the Fortune 500 list this year
The benefits of drug reformulation
May 13 by Leila HawkinsPharma IQ finds out about the advantages of drug reformulation to develop medication that serves unmet needs
Trust in pharma has grown since the pandemic, survey finds
April 29 by Leila HawkinsPandemic boosts confidence in pharma according to the 2022 Edelman Trust Barometer
Integrate or disintegrate?
October 30 by Alan KennedyIntroducing the dos and don't of collaborative working in a pharma-logistics contextSince its emergence as a realistic organisational model in the final quarter of the last century the business potent...